Definitive Contract 75N93024C00073
Award Date 9/3/24
Potential Completion Date 9/2/27
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- Tetracore, Inc. was awarded a $299,973 firm fixed price Small Business Innovation Research Phase I contract by the National Institute of Allergy and Infectious Diseases to develop a rapid molecular assay for point-of-care detection of Treponema pallidum. Work will be performed in Potomac, Maryland and involves research to create a new syphilis detection test with a faster turnaround time. As a small business, Tetracore specializes in assays and reagents for infectious disease detection and has...
- This is a firm fixed-price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services, to Ai Biosciences, Inc., a small disadvantaged business, through the Small Business Innovation Research (SBIR) program. The contract is for the development of a point-of-care diagnostic test to detect gonorrhea and determine antimicrobial susceptibility. The potential value of the contract is $299,652.00, and the period of performance runs from August 8,...
- This is a federal contract award to the University of Maryland, Baltimore (UMB) for a Fiscal Year 2022 Broad Agency Announcement (BAA) Topic 18.2 focused on work related to the molecular detection of Treponema pallidum, the causative agent of syphilis. The $2,239,558.00 cost-no-fee contract was awarded on September 30, 2022 by the Centers for Disease Control and Prevention (CDC) and has an ultimate completion date of April 22, 2025. The contract does not have a set-aside designation. Key aspects...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
- This is a $299,988 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Zymeron Corporation, a minority-owned small business. The contract is for the development of novel, low-cost, real-time point-of-care (POC) assays for HIV viral load monitoring, HIV drug resistance monitoring, and pharmacological adherence monitoring. This contract was awarded under the Small Business Innovation...
- This is a $4,590,862.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Sorrento Therapeutics, Inc., a small disadvantaged business. The contract is for the "DEVELOPMENT OF IN VITRO FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES", which was a Broad Agency Announcement (BAA) research area. The contract has a period of performance through May 2, 2025...
- This is a $4,960,081.66 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Social & Scientific Systems, Inc., a subsidiary of DLH Holdings Corp. The contract is for a clinical study of a single-use, point-of-care molecular diagnostic device for the detection of sexually transmitted infections including Neisseria gonorrhoeae, Trichomonas vaginalis, and Chlamydia trachomatis using vaginally...
- This is a $299,986 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Big Eye Diagnostics Inc., a small business manufacturer, for the development and validation of novel diagnostic biomarkers for malaria and select neglected tropical diseases. The contract is part of NIAID's Small Business Innovation Research (SBIR) program, which provides funding to small businesses for innovative research and development. The objective is to create rapid,...
- <p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
- This is a $2,299,958.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Baebies, Inc., a small business manufacturer of medical diagnostic equipment and devices. The contract is for the development of a "SIMPLE MULTIPLEXED PLATFORM FOR SELF-ADMINISTERED HIV AND HEPATITIS B TESTING" under the SBIR Program Phase I. As a small business contractor, Baebies has prior...